Domino�� might not be the first place that comes to mind for the best slice in town but the retail chain is growing a lot faster than you might think.
Today the company said revenue was up 6.9% in the third quarter to $404 million while net income jumped 18% to $30.6 million.
But the real impressive story for Domino's Pizza Domino's Pizza is its long term strategy. You might recall back in 2009 its CEO famously acknowledged in a commercial that Domino�� pizza doesn�� taste good. He apologized for its poor ingredients and promised to improve the recipe.
His honesty worked; domestic same store sales grew 14.3% the following quarter. Since January 2010, shares of Domino�� have been crushing the competition rising 750% while Papa John�� grew 193%, Pizza Hut owner YUM! brands YUM! brands is up 93% and McDonalds 51%.
Top Insurance Companies To Own For 2015: CirTran Corp (CIRC)
CirTran Corporation, incorporated on March 23, 1987, manufactures, markets, and distributes internationally an energy drink under a license with Playboy Enterprises, Inc. (Playboy) through its subsidiary, CirTran Beverage Corporation. It operates in Beverage Distribution and Contract Manufacturing segments. In the United States, it provides a mix of high- and medium-volume turnkey manufacturing services and products using various high-tech applications for electronics original equipment manufacturers (OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. The Company�� services include pre-manufacturing, manufacturing, and post-manufacturing services.
Beverage Distribution
CirTran Beverage Corporation (CirTran Beverage) manufactures, markets, and distributes Playboy-licensed energy drinks, flavored water beverages, and related merchandise through various distribution channels. As of December 31, 2012, the Company had 65 countries throughout Europe, Africa, Australia, the Pacific, and the Middle East.
Contract Marketing
CirTran Products Corp. pursues contract-manufacturing relationships in the domestic consumer products markets, including products in areas, such as home/garden, kitchen, health/beauty, toys, licensed merchandise, and apparel for film, television, sports, and other entertainment properties. The Company concentrates its product development efforts into three areas: home and kitchen appliances, beauty products, and licensed merchandise. Through CirTran - Asia, Inc., the Company designs, manufactures, and supplies products in the international electronics, consumer products, and general merchandise industries for various marketers, distributors, and retailers selling overseas. This subsidiary provides manufacturing services to the direct-response and retail consumer markets.
The Company competes with Hansen�! � Energy, Diet Red, Monster Energy, Lost Energy, Joker Mad Energy, Ace Energy, Unbound Energy, Rumba energy juice, Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, 180, Extreme Energy Shot, Red Devil, Rip It, NOS, Boo Koo, and Vitaminenergy.
Advisors' Opinion:- [By CRWE]
Last Friday, CIRC remained (0.00%) +0.000 at $.0005 at the close (ref. google finance August 30, 2013 ��Close).
CirTran Corporation has recently filed its Quarterly Report on Form 10-Q for the period ended June 30, 2013, showing continued growth in sales and a dramatic improvement in profits. CirTran�� sales were again driven by its Playboy Energy Drink line, which has grown to represent nearly 98% of revenues.
For the quarter, CirTran previously reported sales of $1,096,691, a 247% increase over the $315,755 reported for the same period a year ago. For the six months ended June 30, 2013, CirTran reported sales of 1,964,843, a 110% improvement over the $934,455 reported for the first half of 2012.
Top 10 Income Companies To Buy For 2014: Ocado Group PLC (OCDO)
Ocado Group plc is a United Kingdom-based holding company. The Company�� principal activities are the retailing, logistics and distribution of grocery and consumer goods and the development and monetisation of intellectual property and technology for the online retailing, logistics and distribution of these goods. The Company is an online grocery retailer. The Company�� subsidiaries include Ocado Holdings Limited, Ocado Limited, Ocado Information Technology Limited, Last Mile Developments Limited and Last Mile Developments Limited. Advisors' Opinion:- [By Sarah Jones]
Rio Tinto Group and Anglo American Plc (AAL) retreated more than 2.5 percent as copper and lead declined. Eurasian Natural Resources Corp. (ENRC) sank 6.8 percent as analysts downgraded the shares. Standard Life Plc slipped 1.2 percent as Chief Financial Officer Jackie Hunt resigned to move to a rival insurer. Ocado Group Plc (OCDO) fell for the first day this week as the online grocer ruled out a takeover by William Morrison Supermarkets Plc.
Top 10 Income Companies To Buy For 2014: Pacific Biosciences of California Inc.(PACB)
Pacific Biosciences of California, Inc., a development stage company, develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a technology platform that enables single molecule, real-time (SMRT) for the detection of biological processes. It primarily focuses on the deoxyribonucleic acid sequencing market. The company?s product includes the PacBio RS, a sequencing platform, which consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits. The company?s customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Advisors' Opinion:- [By Geoff Gannon]
1. Steel Excel (SXCL)
2. FormFactor (FORM)
3. Imation (IMN)
4. Tuesday Morning (TUES)
5. Pacific Biosciences (PACB)
6. Maxygen (MAXY)
7. Westell (WSTL)
8. Volt Information Sciences (VISI)
9. Yasheng Group (YHGG) - [By Alex Planes]
However, Fool biotech expert Brian Orelli points out one big caveat: Once sequencing companies make these tests accessible, margins may collapse beyond the ability of volume sales to make up the difference. At least Illumina (and Life Tech) are in the driver's seat on margins, as it's unlikely that lesser-funded sequencing competitors Affymetrix (NASDAQ: AFFX ) and Pacific Biosciences (NASDAQ: PACB ) can muster the resources to push out sequencing at cost-effective scale before their peers.
Top 10 Income Companies To Buy For 2014: Carrizo Oil & Gas Inc.(CRZO)
Carrizo Oil & Gas, Inc., an independent energy company, engages in the exploration, development, and production of oil and gas in the United States and the United Kingdom. The company holds interest in crude oil and liquids plays in the Eagle Ford Shale in south Texas; the Niobrara Formation in Colorado; the Utica Shale in Ohio and Pennsylvania; and the Huntington Field in the U.K. North Sea. It also owns interest in natural gas plays in the Barnett Shale in North Texas; and the Marcellus Shale in Pennsylvania, New York, and West Virginia; as well as in the onshore Gulf Coast area and the Camp Hill field in Texas. As of December 31, 2011, the company had a proved oil and gas reserves of 935.6 billion cubic feet equivalent comprising 728 billion cubic feet of natural gas; 30.5 million barrels of oil or other liquid hydrocarbons (MMbbls) of oil and condensate; and 4.1 MMbbls of natural gas liquids, as well as operated 349 gross producing oil and gas wells. Carrizo Oil & Gas, Inc. was founded in 1993 and is based in Houston, Texas.
Advisors' Opinion:- [By Richard Moroney]
Carrizo Oil & Gas (CRZO) focuses on proven shale properties in Colorado, Ohio, Pennsylvania, and Texas. Its Eagle Ford operations, which span more than 50,000 drillable acres in Texas, have estimated oil and gas reserves of 173 million barrels, or about 42% of Carrizo's total.
- [By Aimee Duffy]
Production results have fueled record numbers for producers big and small, including EOG Resources (NYSE: EOG ) and Carrizo Oil & Gas (NASDAQ: CRZO ) . EOG is the largest producer in the play, and production has exceeded management's expectations, reaching 153,000 barrels of oil equivalent per day by the end of the first quarter of this year. Carrizo is a much smaller operation, but its production has also exceeded management's expectations, reaching 9,500 bpd in the second quarter.
- [By Robert Rapier]
Eagle Ford crude driller Carrizo Oil & Gas (Nasdaq: CRZO) is up nearly 14 percent since we added it to the Aggressive Portfolio on Dec. 11, and here too there was no company-specific news. Rather, Carrizo appears to have benefited from the end in mid-December of the sharp autumn correction in drillers’ share prices.
Top 10 Income Companies To Buy For 2014: Flushing Financial Corporation (FFIC)
Flushing Financial Corporation operates as the holding company of Flushing Savings Bank, FSB that provides banking products and services primarily to consumers and businesses. The company?s deposit products include savings accounts, money market accounts, demand accounts, negotiable order of withdrawal accounts, and certificates of deposit. Its loan products portfolio comprises one-to-four family, multi-family residential, and commercial real estate mortgage loans; construction loans, primarily for residential properties; small business administration loans and other small business loans; mortgage loan surrogates, such as mortgage-backed securities; U.S. government securities, corporate fixed-income securities, and other marketable securities; and consumer loans, including overdraft lines of credit. The company also offers Internet banking services through iGObanking.com. As of December 31, 2010, it conducted its business through 16 full-service offices located in the New York City Boroughs of Queens, Brooklyn, and Manhattan, as well as in Nassau County, New York. The company was founded in 1929 and is based in Lake Success, New York.
Advisors' Opinion:- [By Tim Melvin]
I always find it very interesting to see what long-term investors are selling in a given quarter. Kahn Brothers lightened up on many financials that have shot up and now trade above book value. The firm sold out of Flushing Financial (FFIC), TCF Financial (TCB) and Dime Community Bank (DCOM). Khan apparently shares my views on the large-cap drug stocks, easing up on both Pfizer (PFE) and Bristol Meyers (BMY) over the summer. Khan Brothers also sold the last of the Travelers shares (TRV) it has owned since 2008 at more than twice the purchase price.
Top 10 Income Companies To Buy For 2014: RAIT Financial Trust(RAS)
RAIT Financial Trust operates as a self-managed and self-advised real estate investment trust (REIT). The company, through its subsidiaries, invests in, manages, and services real estate-related assets with a focus on commercial real estate. It also offers a set of debt financing options to the commercial real estate industry along with fixed income trading and advisory services. In addition, RAIT Financial Trust owns and manages a portfolio of commercial real estate properties, and manages real estate-related assets for third parties. The company qualifies as a REIT for federal income tax purposes. As a REIT, it would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. RAIT Investment Trust was founded in 1997 and is based in Philadelphia, Pennsylvania.
Advisors' Opinion:- [By Marc Bastow]
Commercial real-estate loan originator and real estate investment trust RAIT Financial Trust (RAS) raised its quarterly dividend 6% to 17 cents per share, payable April 30 to shareholders of record as of April 4. At more than an 8% yield, RAS stock has the highest yield on this week’s list of dividend stocks.
RAS Dividend Yield: 8.14%.
Top 10 Income Companies To Buy For 2014: Oncothyreon Inc .(ONTY)
Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.
Advisors' Opinion:- [By James E. Brumley]
On paper, Oncothyreon Inc. (NASDAQ:ONTY) doesn't look like a particularly compelling investment. The pre-revenue biotech company is poised to keep booking sizable losses as it continues to work on its lung cancer drug tecemotide (formerly Stimuvax), which has rejected by the FDA last year but is still being reworked for a slightly different illness than was being targeted initially. And, with no other Phase 3 drug in its pipeline, traders may be rightfully wondering if there's any real catalyst for ONTY in the foreseeable future.
- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Oncothyreon (ONTY), which develops and markets synthetic vaccines and small molecules that treat cancer patients. This stock hasn't done much so far in 2013, with shares down modestly by 3.9%.
If you take a look at the chart for Oncothyreon, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last month and change, with shares moving between $1.63 on the downside and $1.95 on the upside. Shares of ONTY have been finding some buying interest of late right above its 50-day moving average of $1.73 a share. This stock is now starting to push within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.
Traders should now look for long-biased trades in ONTY if it manages to break out above some near-term overhead resistance levels at $1.93 to $1.95 a share and then once it takes out more resistance at $1.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 689,364 shares. If that breakout triggers soon, then ONTY will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $2.12 a share to $2.70 a share.
Traders can look to buy ONTY off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.73 a share or around more support at $1.63 a share. One can also buy ONTY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
No comments:
Post a Comment